APA (7th ed.) Citation

S, R., M, B., V, S., R, L., F, B., V, O., . . . C, T. (2023). Interleukin-62/lymphocyte as a proposed predictive index for COVID-19 patients treated with monoclonal antibodies. Clinical and experimental medicine, 23(7), 3681. https://doi.org/10.1007/s10238-023-01081-6

Chicago Style (17th ed.) Citation

S, Rotundo, et al. "Interleukin-62/lymphocyte as a Proposed Predictive Index for COVID-19 Patients Treated with Monoclonal Antibodies." Clinical and Experimental Medicine 23, no. 7 (2023): 3681. https://doi.org/10.1007/s10238-023-01081-6.

MLA (9th ed.) Citation

S, Rotundo, et al. "Interleukin-62/lymphocyte as a Proposed Predictive Index for COVID-19 Patients Treated with Monoclonal Antibodies." Clinical and Experimental Medicine, vol. 23, no. 7, 2023, p. 3681, https://doi.org/10.1007/s10238-023-01081-6.